NFJ Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-421
Closed -$33.7K 228
2026
Q1
$33.7K Buy
421
+39
+10% +$3.21K ﹤0.01% 196
2025
Q4
$32.6K Hold
382
﹤0.01% 195
2025
Q3
$29.7K Hold
382
﹤0.01% 226
2025
Q2
$29.9K Hold
382
﹤0.01% 251
2025
Q1
$27.7K Hold
382
﹤0.01% 271
2024
Q4
$28.3K Sell
382
-22,816
-98% -$1.6M ﹤0.01% 262
2024
Q3
$1.53M Sell
23,198
-460,132
-95% -$33.4M 0.04% 235
2024
Q2
$44.6M Sell
483,330
-63,487
-12% -$5.62M 1.37% 13
2024
Q1
$52.3M Sell
546,817
-49,600
-8% -$4.17M 1.43% 13
2023
Q4
$45.5M Buy
596,417
+36,766
+7% +$2.56M 1.26% 23
2023
Q3
$38.8M Buy
559,651
+419,332
+299% +$33.7M 1.13% 29
2023
Q2
$13.2M Sell
140,319
-37,638
-21% -$3.27M 0.35% 85
2023
Q1
$14.7M Buy
+177,957
New +$14M 0.39% 75
2021
Q4
Sell
-39,879
Closed -$4.51M 367
2021
Q3
$4.51M Sell
39,879
-1,033
-3% -$118K 0.09% 230
2021
Q2
$4.24M Sell
40,912
-4,189
-9% -$395K 0.08% 249
2021
Q1
$3.77M Buy
+45,101
New +$3.81M 0.08% 261

Other funds holding EW

NFJ Investment Group's EW Position: Q2 2026 in Review

NFJ Investment Group sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 421 shares — an estimated $33.7K sold.

NFJ Investment Group first reported a position in EW in Q1 2021 and held it in 16 quarters. The position peaked at $52.3M in Q1 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • NFJ Investment Group reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • NFJ Investment Group sold 421 Edwards Lifesciences shares in Q2 2026, an estimated $33.7K.
  • NFJ Investment Group first reported a position in Edwards Lifesciences in Q1 2021 and held it in 16 quarters.
  • NFJ Investment Group's Edwards Lifesciences position peaked at $52.3M in Q1 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on NFJ Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.